Charles S. Berkman
2015 - Ligand Pharmaceuticals
In 2015, Charles S. Berkman earned a total compensation of $1.5M as Vice President and General Counsel at Ligand Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $117,882 |
|---|---|
| Option Awards | $517,400 |
| Salary | $308,592 |
| Stock Awards | $512,641 |
| Other | $5,937 |
| Total | $1,462,452 |
Berkman received $517.4K in option awards, accounting for 35% of the total pay in 2015.
Berkman also received $117.9K in non-equity incentive plan, $308.6K in salary, $512.6K in stock awards and $5.9K in other compensation.
Rankings
In 2015, Charles S. Berkman's compensation ranked 6,110th out of 13,638 executives tracked by ExecPay. In other words, Berkman earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,110 out of 13,638 | 55th |
Division Manufacturing | 2,284 out of 5,190 | 56th |
Major group Chemicals And Allied Products | 823 out of 1,854 | 56th |
Industry group Drugs | 658 out of 1,528 | 57th |
Industry Pharmaceutical Preparations | 513 out of 1,182 | 57th |
Source: SEC filing on April 14, 2017.
Berkman's colleagues
We found five more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2015.
2015
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2015
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
2015
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
2015
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
2015
Melanie Herman
Ligand Pharmaceuticals